The Effect of a Diet Based on Low Sodium and Slowly Absorbed Carbohydrates on the Incidence of Refeeding Syndrome in Patients With Head and Neck Cancer
The Prevention of Refeeding Syndrome by a Diet Regime in Patient With Head and Neck Cancer
1 other identifier
interventional
32
1 country
1
Brief Summary
The study is based on a master thesis which showed that 72% of patients with head and neck cancer admitted to a Danish hospital (Rigshospitalet, Copenhagen) developed refeeding syndrome after admission. Refeeding syndrome is characterized by a decrease in plasma phosphate levels, which develops after the reintroduction of an adequate food intake after a longer period of starvation or semi-starvation. This normally happens within 7 days after reintroduction of food. The aim of this study is to minimize the incidence of refeeding syndrome in this group of patients by reintroducing food slowly and by providing a diet low in sodium and high in slowly absorbed carbohydrates as a prevention diet (i.e. given before a potential decrease in plasma phosphate levels appear). Both patients that eat normally, patients with eating tubes and patients with central vein catheters are included in the study, but the data will be evaluated both together and separately.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2013
CompletedStudy Start
First participant enrolled
May 1, 2013
CompletedFirst Posted
Study publicly available on registry
May 3, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedNovember 13, 2019
November 1, 2019
9 months
April 22, 2013
November 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurence of Refeeding events
Measured by a decrease in plasma phosphate levels.
daily, starting from day of admission and until day 7 of the treatment period or until discharge from the hospital if before day 7
Secondary Outcomes (4)
Incidence of infections
daily, starting from day of admission and until day 7 of the treatment period or until discharge from the hospital if before day 7
Length of stay
Number of days from admission until discharge from the hospital, assessed up to 6 month
Amount of days admitted to a Intensive-care unit
Number of days from admission until discharge from the Intensive-care unit, assessed up to 6 month
Other complications than infections
daily, starting from day of admission and until day 7 of the treatment period or until discharge from the hospital if before day 7
Other Outcomes (1)
Nutritional status
daily, starting from day of admission and until day 7 of the treatment period or until discharge from the hospital if before day 7
Study Arms (2)
Low sodium diet
EXPERIMENTALLow sodium diet
Control
NO INTERVENTIONStandard diet regime
Interventions
Eligibility Criteria
You may qualify if:
- authoritative
- written consent
- suspected of or diagnosed with head and neck cancer
- Increased risk of Refeeding syndrome, defined by one of the below:
- A-score of 1 in the Nutritional Risk Screening 2002 (NRS 2002)
- high levels of alcohol consumption (men\>168g alcohol/week corresponding to approximately 14 units, women\>84g alcohol/week corresponding to approximately 7 units)
- anamnesis with prior radiation therapy
- Head and neck pain that require pain management or inhibits food intake
- the presence of problems with eating that are so serious that the food intake is inhibited
You may not qualify if:
- minor or declared incapable of managing own affairs
- patients that are incapable of understanding and communicating in Danish
- patients with dementia
- if the patient is not diagnosed with head and neck cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rigshospitalet
Copenhagen Ø, 2100, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jens R. Andersen, MD, lektor
University of Copenhagen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 22, 2013
First Posted
May 3, 2013
Study Start
May 1, 2013
Primary Completion
February 1, 2014
Study Completion
February 1, 2014
Last Updated
November 13, 2019
Record last verified: 2019-11